Me. Brunkow et al., Bone dysplasia sclerosteosis results from loss of the SOST gene product, anovel cystine knot-containing protein, AM J HU GEN, 68(3), 2001, pp. 577-589
Citations number
51
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Molecular Biology & Genetics
Sclerosteosis is an autosomal recessive sclerosing bone dysplasia character
ized by progressive skeletal overgrowth. The majority of affected individua
ls have been reported in the Afrikaner population of South Africa, where a
high incidence of the disorder occurs as a result of a founder effect. Homo
zygosity mapping in Afrikaner families along with analysis of historical re
combinants localized sclerosteosis to an interval of similar to2 cM between
the loci D17S1787 and D17S930 on chromosome 17q12-q21. Here we report two
independent mutations in a novel gene, termed "SOST." Affected Afrikaners c
arry a nonsense mutation near the amino terminus of the encoded protein, wh
ereas an unrelated affected person of Senegalese origin carries a splicing
mutation within the single intron of the gene. The SOST gene encodes a prot
ein that shares similarity with a class of cystine knot-containing factors
including dan, cerberus, gremlin, prdc, and caronte. The specific and progr
essive effect on bone formation observed in individuals affected with scler
osteosis, along with the data presented in this study, together suggest tha
t the SOST gene encodes an important new regulator of bone homeostasis.